Lower NLRP3 Inflammasome activity in NAG-1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity

Por Wang, Xingya, Chrysovergis, Kali, Kosak, Justin, Eling, Thomas E.
Publicado em 2013

MT1-MMP–dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth

Por Holmbeck, Kenn, Bianco, Paolo, Chrysovergis, Kali, Yamada, Susan, Birkedal-Hansen, Henning
Publicado em 2003

The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo

Por Wang, Xingya, Chrysovergis, Kali, Bienstock, Rachelle J., Shim, Minsub, Eling, Thomas E.
Publicado em 2011

A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2

Por Iguchi, Genzo, Chrysovergis, Kali, Lee, Seong-Ho, Baek, Seung Joon, Langenbach, Robert, Eling, Thomas E.
Publicado no Cancer Lett (2009)

15-Lipoxygenase-1 Activates Tumor Suppressor p53 Independent of Enzymatic Activity

Por Zhu, Hong, Glasgow, Wayne, George, Margaret D., Chrysovergis, Kali, Olden, Kenneth, Roberts, John D., Eling, Thomas
Publicado em 2008

hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling

Por Wang, Xingya, Chrysovergis, Kali, Kosak, Justin, Kissling, Grace, Streicker, Mike, Moser, Glenda, Li, Ruifang, Eling, Thomas E.
Publicado em 2014

NAG-1/GDF15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism

Por Chrysovergis, Kali, Wang, Xingya, Kosak, Justin, Lee, Seong-Ho, Kim, Jong Sik, Foley, Julie F., Travlos, Greg, Singh, Shubha, Baek, Seung Joon, Eling, Thomas E.
Publicado em 2014